Teva Pharmaceutical (Israel) Today
| TEVA Stock | ILA 5,945 55.00 0.93% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Teva Pharmaceutical is trading at 5945.00 as of the 26th of February 2025, a 0.93 percent increase since the beginning of the trading day. The stock's open price was 5890.0. Teva Pharmaceutical has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. The company has 1.11 B outstanding shares. More on Teva Pharmaceutical Industries
Moving together with Teva Stock
Moving against Teva Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Teva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Teva Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Teva Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Kaare Schultz |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Teva Pharmaceutical Industries (TEVA) is traded on Tel Aviv Stock Exchange in Israel and employs 34,004 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 39.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Teva Pharmaceutical operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.11 B outstanding shares.
Teva Pharmaceutical Industries has accumulated about 2.44 B in cash with 1.59 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check Teva Pharmaceutical Probability Of Bankruptcy
Ownership AllocationTeva Pharmaceutical shows a total of 1.11 Billion outstanding shares. About 93.93 % of Teva Pharmaceutical outstanding shares are held by general public with 0.77 (%) owned by insiders and only 5.3 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Teva Ownership Details
Teva Pharmaceutical Risk Profiles
Although Teva Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Teva Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.52 | |||
| Semi Deviation | 3.77 | |||
| Standard Deviation | 4.19 | |||
| Variance | 17.6 |
Teva Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Teva Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Teva Pharmaceutical Corporate Directors
| Nechemia Peres | Independent Director | Profile | |
| JeanMichel Halfon | Statutory - independent director | Profile | |
| Perry Nisen | Independent Director | Profile | |
| Gerald Lieberman | Independent Director | Profile |
Other Information on Investing in Teva Stock
Teva Pharmaceutical financial ratios help investors to determine whether Teva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.